🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the immune response and the safety of a primary series schedule...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-01
Trial ID
NCT01839188
Treatments Being Tested
This is a study to assess the safety, tolerability, and immunogenicity of V...
Status
Completed
Location
Multiple Locations
Start Date
2011-04-19
Trial ID
NCT01337167
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity and safety of t...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00355121
The aim of the study is to assess safety and immunogenicity of a single dos...
Status
Completed
Location
Multiple Locations
Start Date
2012-07
Trial ID
NCT01642589
The purpose of this study was to evaluate the immunogenicity and safety of ...
Status
Completed
Location
Multiple Locations
Start Date
2005-04
Trial ID
NCT00777257
The aim of the study is to further characterize the safety and immunogenici...
Status
Completed
Location
Multiple Locations
Start Date
2012-07
Trial ID
NCT01659996
Treatments Being Tested
The purpose of the study was to evaluate the immunogenicity and describe th...
Status
Completed
Location
Multiple Locations
Start Date
2014-07-22
Trial ID
NCT02199691
Treatments Being Tested
The primary objectives of this study are to evaluate the immunogenicity and...
Status
Completed
Location
Multiple Locations
Start Date
2012-03-30
Trial ID
NCT01553279
Treatments Being Tested
The purpose of this study was to evaluate the optimal vaccination schedule ...
Status
Completed
Location
Multiple Locations
Start Date
2009-12-16
Trial ID
NCT01049035
Treatments Being Tested
Primary objective: This study aimed to demonstrate the non-inferiority of ...
Status
Completed
Location
Investigational Site Number : 2031006
Start Date
2018-12-14
Trial ID
NCT03547271